KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™
Provided By Business Wire
Last update: Apr 18, 2025
Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.
The release was issued in error by Aditxt, Inc..
A replacement release will not be issued at this time.
1.23
-0.02 (-1.6%)
Find more stocks in the Stock Screener
ADTX Latest News and Analysis
3 days ago - ChartmillUnusual volume stocks in Wednesday's sessionThe trading volume of these stocks is deviating from the norm in today's session.
9 days ago - ChartmillWhich stocks have an unusual volume on Thursday?Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
10 days ago - ChartmillLet's have a look at the top gainers and losers one hour before the close of the markets of today's session.Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
